By Professor Glenda Halliday

Journal articles

Hardwick SA; Bassett SD; Kaczorowski D; Blackburn J; Barton K; Bartonicek N; Carswell SL; Tilgner HU; Loy C; Halliday G; Mercer TR; Smith MA; Mattick JS, 2019, 'Targeted, high-resolution RNA sequencing of non-coding genomic regions associated with neuropsychiatric functions', Frontiers in Genetics, 10, pp. 309, http://dx.doi.org/10.3389/fgene.2019.00309

Tan RH; Yang Y; McCann H; Shepherd C; Halliday GM; Whitwell J, 2019, 'Von economo neurons in behavioral variant frontotemporal dementia with underlying Alzheimer's disease', Journal of Alzheimer's Disease, 69, pp. 963 - 967, http://dx.doi.org/10.3233/JAD-180900

Pires G; Prelli F; Halliday GM; McElligott S; Drusinsky S; Wisniewski T; Drummond E, 2019, 'O4‐01‐06: SECERNIN‐1 IS A NOVEL PHOSPHORYLATED TAU BINDING PROTEIN THAT ACCUMULATES IN ALZHEIMER'S DISEASE AND NOT IN OTHER TAUOPATHIES', Alzheimer's & Dementia, 15, http://dx.doi.org/10.1016/j.jalz.2019.06.4745

Farrell AW; Halliday GM; Lyons JG, 2018, 'Brahma deficiency in keratinocytes promotes UV carcinogenesis by accelerating the escape from cell cycle arrest and the formation of DNA photolesions', Journal of Dermatological Science, 92, pp. 254 - 263, http://dx.doi.org/10.1016/j.jdermsci.2018.11.006

Bonham LW; Karch CM; Fan CC; Tan C; Geier EG; Wang Y; Wen N; Broce IJ; Li Y; Barkovich MJ; Ferrari R; Hardy J; Momeni P; Höglinger G; Müller U; Hess CP; Sugrue LP; Dillon WP; Schellenberg GD; Miller BL; Andreassen OA; Dale AM; Barkovich AJ; Yokoyama JS; Desikan RS; Hernandez DG; Nalls MA; Rohrer JD; Ramasamy A; Kwok JBJ; Dobson-Stone C; Schofield PR; Halliday GM; Hodges JR; Piguet O; Bartley L; Thompson E; Haan E; Hernández I; Ruiz A; Boada M; Borroni B; Padovani A; Cruchaga C; Cairns NJ; Benussi L; Binetti G; Ghidoni R; Forloni G; Albani D; Galimberti D; Fenoglio C; Serpente M; Scarpini E; Clarimón J; Lleó A; Blesa R; Waldö ML; Nilsson K; Nilsson C; MacKenzie IRA; Hsiung GYR; Mann DMA; Grafman J; Morris CM; Attems J; Griffiths TD; McKeith IG; Thomas AJ; Pietrini P; Huey ED; Wassermann EM; Baborie A; Jaros E; Tierney MC; Pastor P; Razquin C; Ortega-Cubero S; Alonso E; Perneczky R; Diehl-Schmid J; Alexopoulos P; Kurz A; Rainero I; Rubino E; Pinessi L; Rogaeva E; George-Hyslop PS; Rossi G; Tagliavini F; Giaccone G; Rowe JB; Schlachetzki JCM; Uphill J; Collinge J; Mead S; Danek A; Van Deerlin VM; Grossman M; Trojanowski JQ, 2018, 'CXCR4 involvement in neurodegenerative diseases', Translational Psychiatry, 8, pp. 73, http://dx.doi.org/10.1038/s41398-017-0049-7

Schwartz RS; Halliday GM; Soh D; Cordato DJ; Kril JJ, 2018, 'Impact of small vessel disease on severity of motor and cognitive impairment in Parkinson's disease', Journal of Clinical Neuroscience, 58, pp. 70 - 74, http://dx.doi.org/10.1016/j.jocn.2018.10.029

Guerreiro R; Orme T; Neto JL; Bras J; Hardy J; Kun-Rodrigues C; Darwent L; Neto J; Carmona S; Ansorge O; Parkkinen L; Morgan K; Brown K; Braae A; Barber I; Troakes C; Al-Sarraj S; Lashley T; Holton J; Compta Y; Revesz T; Lees A; Zetterberg H; Escott-Price V; Pickering-Brown S; Mann D; Singleton A; Hernandez D; Ross O; Dickson D; Graff-Radford N; Ferman T; Petersen R; Boeve B; Heckman M; Trojanowski JQ; Van Deerlin V; Cairns N; Morris J; Stone DA; Eicher J; Clark L; Honig L; Marder K; Serrano G; Beach T; Galasko D; Masliah E; Rogaeva E; St. George-Hyslop P; Clarimon J; Lleo A; Morenas-Rodriguez E; Pastor P; Diez-Fairen M; Aquilar M; Shepherd C; Halliday G; Tienari P; Myllykangas L; Oinas M; Santana I; Lesage S; Londos E; Lemstra A, 2018, 'LRP10 in α-synucleinopathies', The Lancet Neurology, 17, pp. 1032 - 1033, http://dx.doi.org/10.1016/S1474-4422(18)30399-5

Zhao Y; Keshiya S; Atashrazm F; Gao J; Ittner LM; Alessi DR; Halliday GM; Fu Y; Dzamko N, 2018, 'Nigrostriatal pathology with reduced astrocytes in LRRK2 S910/S935 phosphorylation deficient knockin mice', Neurobiology of Disease, 120, pp. 76 - 87, http://dx.doi.org/10.1016/j.nbd.2018.09.003

Atashrazm F; Hammond D; Perera G; Dobson-Stone C; Mueller N; Pickford R; Kim WS; Kwok JB; Lewis SJG; Halliday GM; Dzamko N, 2018, 'Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s disease', Scientific Reports, 8, http://dx.doi.org/10.1038/s41598-018-33921-x

Kim WS; He Y; Phan K; Ahmed RM; Rye KA; Piguet O; Hodges JR; Halliday GM, 2018, 'Altered high density lipoprotein composition in behavioral variant frontotemporal dementia', Frontiers in Neuroscience, 12, http://dx.doi.org/10.3389/fnins.2018.00847

Devenney EM; Ahmed RM; Halliday G; Piguet O; Kiernan MC; Hodges JR, 2018, 'Psychiatric disorders in C9orf72 kindreds study of 1,414 family members', Neurology, 91, pp. E1498 - E1507, http://dx.doi.org/10.1212/WNL.0000000000006344

Zhang M; Ferrari R; Tartaglia MC; Keith J; Surace EI; Wolf U; Sato C; Grinberg M; Liang Y; Xi Z; Dupont K; McGoldrick P; Weichert A; McKeever PM; Schneider R; McCorkindale MD; Manzoni C; Rademakers R; Graff-Radford NR; Dickson DW; Parisi JE; Boeve BF; Petersen RC; Miller BL; Seeley WW; van Swieten JC; van Rooij J; Pijnenburg YAL; van der Zee J; van Broeckhoven C; Le Ber I; van Deerlin V; Suh ER; Rohrer JD; Mead S; Graff C; Öijerstedt L; Pickering-Brown S; Rollinson S; Rossi G; Tagliavini F; Brooks WS; Dobson-Stone C; Halliday GM; Hodges JR; Piguet O; Binetti G; Benussi L; Ghidoni R; Nacmias B; Sorbi S; Bruni AC; Galimberti D; Scarpini E; Rainero I; Rubino E; Clarimon J; Lleó A; Ruiz A; Hernández I; Pastor P; Diez-Fairen M; Borroni B; Pasquier F; Deramecourt V; Lebouvier T; Perneczky R; Diehl-Schmid J; Grafman J; Huey ED; Mayeux R; Nalls MA; Hernandez D; Singleton A; Momeni P; Zeng Z; Hardy J; Robertson J; Zinman L; Rogaeva E; Ferrari R; Hernandez DG; Ramasamy A; Kwok JBJ; Brooks WS; Schofield PR; Hodges JR; Bartley L; Thompson E; Hernández I; Ruiz A; Boada M; Padovani A; Cruchaga C; Cairns NJ; Albani D; Galimberti D, 2018, 'A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers', Brain, 141, pp. 2895 - 2907, http://dx.doi.org/10.1093/brain/awy238

Berg D; Adler CH; Bloem BR; Chan P; Gasser T; Goetz CG; Halliday G; Lang AE; Lewis S; Li Y; Liepelt-Scarfone I; Litvan I; Marek K; Maetzler C; Mi T; Obeso J; Oertel W; Olanow CW; Poewe W; Rios-Romenets S; Schäffer E; Seppi K; Heim B; Slow E; Stern M; Bledsoe IO; Deuschl G; Postuma RB, 2018, 'Movement disorder society criteria for clinically established early Parkinson's disease', Movement Disorders, 33, pp. 1643 - 1646, http://dx.doi.org/10.1002/mds.27431

Postuma RB; Poewe W; Litvan I; Lewis S; Lang AE; Halliday G; Goetz CG; Chan P; Slow E; Seppi K; Schaffer E; Rios-Romenets S; Mi T; Maetzler C; Li Y; Heim B; Bledsoe IO; Berg D, 2018, 'Validation of the MDS clinical diagnostic criteria for Parkinson's disease', Movement Disorders, 33, pp. 1601 - 1608, http://dx.doi.org/10.1002/mds.27362

Foxe D; Elan E; Burrell JR; Felicity FV; Devenney E; Kwok JB; Halliday GM; Hodges JR; Piguet O, 2018, 'Intrafamilial phenotypic variability in the C9orf72 gene expansion: 2 case studies', Frontiers in Psychology, 9, http://dx.doi.org/10.3389/fpsyg.2018.01615

Tan RH; Yang Y; Halliday GM, 2018, 'Multiple neuronal pathologies are common in young patients with pathologically proven Frontotemporal lobar degeneration', Neuropathology and Applied Neurobiology, 44, pp. 522 - 532, http://dx.doi.org/10.1111/nan.12455

Forrest SL; Kril JJ; Halliday GM, 2018, 'Reply: Will FTLD-tau work for all when FTDP-17 retires?', Brain, 141, pp. E63, http://dx.doi.org/10.1093/brain/awy179

Baldo B; Sajjad MU; Cheong RY; Bigarreau J; Vijayvargia R; McLean C; Perrier AL; Seong IS; Halliday G; Petersén Å; Kirik D, 2018, 'Quantification of total and mutant huntingtin protein levels in biospecimens using a novel alphaLISA assay', eNeuro, 5, http://dx.doi.org/10.1523/ENEURO.0234-18.2018

Pottier C; Zhou X; Perkerson RB; Baker M; Jenkins GD; Serie DJ; Ghidoni R; Benussi L; Binetti G; López de Munain A; Zulaica M; Moreno F; Le Ber I; Pasquier F; Hannequin D; Sánchez-Valle R; Antonell A; Lladó A; Parsons TM; Finch NCA; Finger EC; Lippa CF; Huey ED; Neumann M; Heutink P; Synofzik M; Wilke C; Rissman RA; Slawek J; Sitek E; Johannsen P; Nielsen JE; Ren Y; van Blitterswijk M; DeJesus-Hernandez M; Christopher E; Murray ME; Bieniek KF; Evers BM; Ferrari C; Rollinson S; Richardson A; Scarpini E; Fumagalli GG; Padovani A; Hardy J; Momeni P; Ferrari R; Frangipane F; Maletta R; Anfossi M; Gallo M; Petrucelli L; Suh ER; Lopez OL; Wong TH; van Rooij JGJ; Seelaar H; Mead S; Caselli RJ; Reiman EM; Noel Sabbagh M; Kjolby M; Nykjaer A; Karydas AM; Boxer AL; Grinberg LT; Grafman J; Spina S; Oblak A; Mesulam MM; Weintraub S; Geula C; Hodges JR; Piguet O; Brooks WS; Irwin DJ; Trojanowski JQ; Lee EB; Josephs KA; Parisi JE; Ertekin-Taner N; Knopman DS; Nacmias B; Piaceri I; Bagnoli S; Sorbi S; Gearing M; Glass J; Beach TG; Black SE; Masellis M; Rogaeva E; Vonsattel JP; Honig LS; Kofler J; Bruni AC; Snowden J; Mann D; Pickering-Brown S, 2018, 'Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study', The Lancet Neurology, 17, pp. 548 - 558, http://dx.doi.org/10.1016/S1474-4422(18)30126-1

van Hummel A; Chan G; van der Hoven J; Morsch M; Ippati S; Suh L; Bi M; Asih PR; Lee WS; Butler TA; Przybyla M; Halliday GM; Piguet O; Kiernan MC; Chung RS; Ittner LM; Ke YD, 2018, 'Selective Spatiotemporal Vulnerability of Central Nervous System Neurons to Pathologic TAR DNA-Binding Protein 43 in Aged Transgenic Mice', American Journal of Pathology, 188, pp. 1447 - 1456, http://dx.doi.org/10.1016/j.ajpath.2018.03.002

Taskesen E; Mishra A; van der Sluis S; Ferrari R; International FTD-Genomics Consortium ; Veldink JH; van Es MA; Smit AB; Posthuma D; Pijnenburg Y, 2018, 'Author Correction: Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS.', Sci Rep, 8, pp. 7789, http://dx.doi.org/10.1038/s41598-018-21308-x

Betzer C; Lassen LB; Olsen A; Kofoed RH; Reimer L; Gregersen E; Zheng J; Calì T; Gai WP; Chen T; Moeller A; Brini M; Fu Y; Halliday G; Brudek T; Aznar S; Pakkenberg B; Andersen JP; Jensen PH, 2018, 'Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation', EMBO Reports, 19, http://dx.doi.org/10.15252/embr.201744617

Ahmed RM; Ke YD; Vucic S; Ittner LM; Seeley W; Hodges JR; Piguet O; Halliday G; Kiernan MC, 2018, 'Physiological changes in neurodegeneration-mechanistic insights and clinical utility', Nature Reviews Neurology, 14, pp. 259 - 271, http://dx.doi.org/10.1038/nrneurol.2018.23

Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Gotz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM, 2018, 'Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies (vol 141, pg 521, 2018)', BRAIN, 141, http://dx.doi.org/10.1093/brain/awy012

Shepherd CE; Yang Y; Halliday GM, 2018, 'Region- and Cell-specific Aneuploidy in Brain Aging and Neurodegeneration', Neuroscience, 374, pp. 326 - 334, http://dx.doi.org/10.1016/j.neuroscience.2018.01.050

Kim WS; Jary E; Pickford R; He Y; Ahmed RM; Piguet O; Hodges JR; Halliday GM, 2018, 'Lipidomics analysis of behavioral variant frontotemporal dementia: A scope for biomarker development', Frontiers in Neurology, 9, http://dx.doi.org/10.3389/fneur.2018.00104

Bodea L-G; Evans HT; Van der Jeugd A; Ittner LM; Delerue F; Kril J; Halliday G; Hodges J; Kiernan MC; Gotz J, 2018, 'Accelerated aging exacerbates a pre-existing pathology in a tau transgenic mouse model (vol 16, 377, 2017)', AGING CELL, 17, http://dx.doi.org/10.1111/acel.12712

Zhao Y; Perera G; Takahashi-Fujigasaki J; Mash DC; Vonsattel JPG; Uchino A; Hasegawa K; Jeremy Nichols R; Holton JL; Murayama S; Dzamko N; Halliday GM, 2018, 'Reduced LRRK2 in association with retromer dysfunction in post-mortem brain tissue from LRRK2 mutation carriers', Brain, 141, pp. 486 - 495, http://dx.doi.org/10.1093/brain/awx344

Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM, 2018, 'Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies', Brain, 141, pp. 521 - 534, http://dx.doi.org/10.1093/brain/awx328

Walsh RR; Krismer F; Galpern WR; Wenning GK; Low PA; Halliday G; Koroshetz WJ; Holton J; Quinn NP; Rascol O; Shaw LM; Eidelberg D; Bower P; Cummings JL; Abler V; Biedenharn J; Bitan G; Brooks DJ; Brundin P; Fernandez H; Fortier P; Freeman R; Gasser T; Hewitt A; Höglinger GU; Huentelman MJ; Jensen PH; Jeromin A; Kang UJ; Kaufmann H; Kellerman L; Khurana V; Klockgether T; Kim WS; Langer C; Lewitt P; Masliah E; Meissner W; Melki R; Ostrowitzki S; Piantadosi S; Poewe W; Robertson D; Roemer C; Schenk D; Schlossmacher M; Schmahmann JD; Seppi K; Shih L; Siderowf A; Stebbins GT; Stefanova N; Tsuji S; Sutton S; Zhang J, 2018, 'Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting', Neurology, 90, pp. 74 - 82, http://dx.doi.org/10.1212/WNL.0000000000004798

Trist BG; Fifita JA; Freckleton SE; Hare DJ; Lewis SJG; Halliday GM; Blair IP; Double KL, 2018, 'Accumulation of dysfunctional SOD1 protein in Parkinson’s disease is not associated with mutations in the SOD1 gene', Acta Neuropathologica, 135, pp. 155 - 156, http://dx.doi.org/10.1007/s00401-017-1779-6

Broce I; Karch CM; Wen N; Fan CC; Wang Y; Hong Tan C; Kouri N; Ross OA; Höglinger GU; Muller U; Hardy J; Momeni P; Hess CP; Dillon WP; Miller ZA; Bonham LW; Rabinovici GD; Rosen HJ; Schellenberg GD; Franke A; Karlsen TH; Veldink JH; Ferrari R; Yokoyama JS; Miller BL; Andreassen OA; Dale AM; Desikan RS; Sugrue LP; Ferrari R; Hernandez DG; Nalls MA; Rohrer JD; Ramasamy A; Kwok JBJ; Dobson-Stone C; Brooks WS; Schofield PR; Halliday GM; Hodges JR; Piguet O; Bartley L; Thompson E; Haan E; Hernández I; Ruiz A; Boada M; Borroni B; Padovani A; Cruchaga C; Cairns NJ; Benussi L; Binetti G; Ghidoni R; Forloni G; Albani D; Galimberti D; Fenoglio C; Serpente M; Scarpini E; Clarimón J; Lleó A; Blesa R; Landqvist Waldö M; Nilsson K; Nilsson C; Mackenzie IRA; Hsiung GYR; Mann DMA; Grafman J; Morris CM; Attems J; Griffiths TD; G McKeith I; Thomas AJ; Pietrini P; Huey ED; Wassermann EM; Baborie A; Jaros E; Tierney MC; Pastor P; Razquin C; Ortega-Cubero S; Alonso E; Perneczky R; Diehl-Schmid J; Alexopoulos P; Kurz A; Rainero I; Rubino E; Pinessi L; Rogaeva E; St George-Hyslop P; Rossi G; Tagliavini F; Giaccone G; Rowe JB; Schlachetzki JCM; Uphill J; Schofield P, 2018, 'Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies', PLoS Medicine, 15, pp. e1002487, http://dx.doi.org/10.1371/journal.pmed.1002487

Guerreiro R; Ross OA; Kun-Rodrigues C; Hernandez DG; Orme T; Eicher JD; Shepherd CE; Parkkinen L; Darwent L; Heckman MG; Scholz SW; Troncoso JC; Pletnikova O; Ansorge O; Clarimon J; Lleo A; Morenas-Rodriguez E; Clark L; Honig LS; Marder K; Lemstra A; Rogaeva E; St George-Hyslop P; Londos E; Zetterberg H; Barber I; Braae A; Brown K; Morgan K; Troakes C; Al-Sarraj S; Lashley T; Holton J; Compta Y; Van Deerlin V; Serrano GE; Beach TG; Lesage S; Galasko D; Masliah E; Santana I; Pastor P; Diez-Fairen M; Aguilar M; Tienari PJ; Myllykangas L; Oinas M; Revesz T; Lees A; Boeve BF; Petersen RC; Ferman TJ; Escott-Price V; Graff-Radford N; Cairns NJ; Morris JC; Pickering-Brown S; Mann D; Halliday GM; Hardy J; Trojanowski JQ; Dickson DW; Singleton A; Stone DJ; Bras J, 2018, 'Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study', The Lancet Neurology, 17, pp. 64 - 74, http://dx.doi.org/10.1016/S1474-4422(17)30400-3

Woerman AL; Kazmi SA; Patel S; Freyman Y; Oehler A; Aoyagi A; Mordes DA; Halliday GM; Middleton LT; Gentleman SM; Olson SH; Prusiner SB, 2018, 'MSA prions exhibit remarkable stability and resistance to inactivation', Acta Neuropathologica, 135, pp. 49 - 63, http://dx.doi.org/10.1007/s00401-017-1762-2

Shine J; Bell P; Matar E; Poldrack R; Lewis SJG; Halliday G; O’Callaghan C, 2018, 'Dopamine Depletion Alters Macroscopic Network Dynamics in Parkinson’s Disease', , http://dx.doi.org/10.1101/382994

Guerreiro R; Escott-Price V; Hernandez D; Kun-Rodrigues C; Ross O; Orme T; Luis Neto J; Carmona S; Dehghani N; Eicher J; Shepherd C; Parkkinen L; Darwent L; Heckman M; Scholz S; Troncoso J; Pletnikova O; Dawson T; Rosenthal L; Ansorge O; Clarimon J; Lleo A; Morenas-Rodriguez E; Clark L; Honig L; Marder K; Lemstra A; Rogaeva E; George-Hyslop PS; Londos E; Zetterberg H; Barber I; Braae A; Brown K; Morgan K; Troakes C; Al-Sarraj S; Lashley T; Holton J; Compta Y; Van Deerlin V; Serrano G; Beach T; Lesage S; Galasko D; Masliah E; Santana I; Pastor P; Diez-Fairen M; Aguilar M; Tienari P; Myllykangas L; Oinas M; Revesz T; Lees A; Boeve B; Petersen R; Ferman T; Graff-Radford N; Cairns N; Morris J; Pickering-Brown S; Mann D; Halliday G; Hardy J; Trojanowski J; Dickson D; Singleton A; Stone D; Bras J; for the International Parkinson’s Disease Genomics Consortium , 2018, 'Heritability and genetic variance of dementia with Lewy bodies', , http://dx.doi.org/10.1101/454249

Dore V; Bourgeat P; Cummins TL; Raniga P; Williams S; Amadoru S; MacLean C; Hinton F; Shepherd C; Halliday GM; Leyton CE; Hodges JR; Ames D; Martins RN; Masters CL; Fripp J; Salvado O; Villemagne VL; Rowe C, 2018, 'IC‐P‐008: VISUAL ASSESSMENT OF β‐AMYLOID PET SCAN IS IMPROVED BY CAPAIBL', Alzheimer's & Dementia, 14, http://dx.doi.org/10.1016/j.jalz.2018.06.2072

Dore V; Bourgeat P; Cummins TL; Raniga P; Williams S; Amadoru S; MacLean C; Hinton F; Shepherd C; Halliday GM; Leyton CE; Hodges JR; Ames D; Martins RN; Masters CL; Fripp J; Salvado O; Villemagne VL; Rowe C, 2018, 'P1‐405: VISUAL ASSESSMENT OF β‐AMYLOID PET SCAN IS IMPROVED BY CAPAIBL', Alzheimer's & Dementia, 14, http://dx.doi.org/10.1016/j.jalz.2018.06.414

Condello C; Aoyagi A; Stöhr J; Lee JC; Rivera BM; Woerman AL; Halliday GM; van Duinen S; Ingelsson M; Lannfelt L; Graff C; Bird TD; Dirk Keene C; Seeley WW; DeGrado WF; Prusiner SB, 2018, 'P4‐233: AGED ALZHEIMER'S DISEASE BRAINS EXHIBIT NUMEROUS Aβ BUT ONLY FEW TAU PRIONS', Alzheimer's & Dementia, 14, http://dx.doi.org/10.1016/j.jalz.2018.07.054

Surmeier DJ; Halliday GM; Simuni T, 2017, 'Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease', Experimental Neurology, 298, pp. 202 - 209, http://dx.doi.org/10.1016/j.expneurol.2017.08.001

Taskesen E; Mishra A; van der Sluis S; Ferrari R; Veldink JH; van Es MA; Smit AB; Posthuma D; Pijnenburg Y; Hernandez DG; Nalls MA; Rohrer JD; Ramasamy A; Kwok JBJ; Dobson-Stone C; Schofield PR; Halliday GM; Hodges JR; Piguet O; Bartley L; Thompson E; Haan E; Hernández I; Ruiz A; Boada M; Borroni B; Padovani A; Cruchaga C; Cairns NJ; Benussi L; Binetti G; Ghidoni R; Forloni G; Albani D; Galimberti D; Fenoglio C; Serpente M; Scarpini E; Clarimón J; Lleó A; Blesa R; Waldö ML; Nilsson K; Nilsson C; Mackenzie IRA; Hsiung GYR; Mann DMA; Grafman J; Morris CM; Attems J; Griffiths TD; McKeith IG; Thomas AJ; Pietrini P; Huey ED; Wassermann EM; Baborie A; Jaros E; Tierney MC; Pastor P; Razquin C; Ortega-Cubero S; Alonso E; Perneczky R; Diehl-Schmid J; Alexopoulos P; Kurz A; Rainero I; Rubino E; Pinessi L; Rogaeva E; St George-Hyslop P; Rossi G; Tagliavini F; Giaccone G; Rowe JB; Schlachetzki JCM; Uphill J; Collinge J; Mead S; Danek A; Van Deerlin VM; Grossman M; Trojanowski JQ; van der Zee J; Van Broeckhoven C; Cappa SF; Leber I; Hannequin D; Golfier V; Vercelletto M; Brice A; Nacmias B; Sorbi S; Bagnoli S; Piaceri I; Nielsen JE; Hjermind LE; Riemenschneider M; Mayhaus M, 2017, 'Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS', Scientific Reports, 7, pp. 8899, http://dx.doi.org/10.1038/s41598-017-09320-z

Halliday G, 2017, 'Pathology and hippocampal atrophy in Alzheimer's disease', The Lancet Neurology, 16, pp. 862 - 864, http://dx.doi.org/10.1016/S1474-4422(17)30343-5

Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM, 2017, 'Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis', Acta neuropathologica communications, 5, pp. 76, http://dx.doi.org/10.1186/s40478-017-0480-2

James Surmeier D; Obeso JA; Halliday GM, 2017, 'Parkinson’s disease is not simply a prion disorder', Journal of Neuroscience, 37, pp. 9799 - 9807, http://dx.doi.org/10.1523/JNEUROSCI.1787-16.2017

Surmeier DJ; Obeso JA; Halliday GM, 2017, 'Response from dual perspectives companion', Journal of Neuroscience, 37, pp. 9815 - 9816

Genoud S; Roberts BR; Gunn AP; Halliday GM; Lewis SJG; Ball HJ; Hare DJ; Double KL, 2017, 'Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain', Metallomics, 9, pp. 1447 - 1455, http://dx.doi.org/10.1039/c7mt00244k

Hsiao JHT; Halliday GM; Kim WS; Hsiao J-H, 2017, 'α-Synuclein regulates neuronal cholesterol efflux', Molecules, 22, pp. 1769, http://dx.doi.org/10.3390/molecules22101769

Obeso JA; Stamelou M; Goetz CG; Poewe W; Lang AE; Weintraub D; Burn D; Halliday GM; Bezard E; Przedborski S; Lehericy S; Brooks DJ; Rothwell JC; Hallett M; DeLong MR; Marras C; Tanner CM; Ross GW; Langston JW; Klein C; Bonifati V; Jankovic J; Lozano AM; Deuschl G; Bergman H; Tolosa E; Rodriguez-Violante M; Fahn S; Postuma RB; Berg D; Marek K; Standaert DG; Surmeier DJ; Olanow CW; Kordower JH; Calabresi P; Schapira AHV; Stoessl AJ, 2017, 'Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy', Movement Disorders, 32, pp. 1264 - 1310, http://dx.doi.org/10.1002/mds.27115

Weissleder C; Kondo MA; Yang C; Fung SJ; Rothmond DA; Wong MW; Halliday GM; Herman MM; Kleinman JE; Webster MJ; Shannon Weickert C, 2017, 'Early-life decline in neurogenesis markers and age-related changes of TrkB splice variant expression in the human subependymal zone', European Journal of Neuroscience, 46, pp. 1768 - 1778, http://dx.doi.org/10.1111/ejn.13623

McKeith IG; Boeve BF; Dickson DW; Halliday G; Taylor JP; Weintraub D; Aarsland D; Galvin J; Attems J; Ballard CG; Bayston A; Beach TG; Blanc F; Bohnen N; Bonanni L; Bras J; Brundin P; Burn D; Chen-Plotkin A; Duda JE; El-Agnaf O; Feldman H; Ferman TJ; Ffytche D; Fujishiro H; Galasko D; Goldman JG; Gomperts SN; Graff-Radford NR; Honig LS; Iranzo A; Kantarci K; Kaufer D; Kukull W; Lee VMY; Leverenz JB; Lewis S; Lippa C; Lunde A; Masellis M; Masliah E; McLean P; Mollenhauer B; Montine TJ; Moreno E; Mori E; Murray M; O'Brien JT; Orimo S; Postuma RB; Ramaswamy S; Ross OA; Salmon DP; Singleton A; Taylor A; Thomas A; Tiraboschi P; Toledo JB; Trojanowski JQ; Tsuang D; Walker Z; Yamada M; Kosaka K, 2017, 'Diagnosis and management of dementia with Lewy bodies', Neurology, 89, pp. 88 - 100, http://dx.doi.org/10.1212/WNL.0000000000004058

Back to profile page